Evidently vs SmarterDx
Two Revenue Integrity & Pre-Bill Review vendors, side by side. Facts from public sources; judgments are ours.
At a glance
Derived from public facts · a rough scale, not a ranking
| Evidently | SmarterDx | |
|---|---|---|
| Pricing model | Enterprise contract (custom) · Pricing not published | Contingency (pay from recoveries) · paid only from net new revenue |
| Speed to go live | SMART on FHIR pilot, then rollout | weeks, sidecar to existing coding workflow |
| Automation model | AI copilot · Surfaces evidence, humans decide | Software platform · AI prebill review, human in loop |
| Built for | Mid-size groups, Enterprise systems | Enterprise systems |
| Security posture | SOC 2 Type II, HIPAA | SOC 2 Type II, HIPAA |
| Company maturity | 6 yrs (est. 2020) | 6 yrs (est. 2020) |
| Financial backing | $15M · Series A | PE-backed (Smarter Technologies, a New Mountain Capital platform) |
| Named customers | 3 named | 3 named |
| Published results | No public numbers | Specific numbers public |
| Documented integrations | 4 listed | 3 listed |
| Third-party validation | KLAS / analyst cited | KLAS / analyst cited |
Bottom line
- Pick Evidently if you want one EHR-embedded chart intelligence layer serving clinicians, CDI, and risk adjustment together.
- Pick SmarterDx if you are a hospital that wants found revenue from every chart with no upfront budget or workflow change.
Evidently
EHR-embedded AI that turns scattered chart data into answers
- Founded
- 2020
- HQ
- San Francisco, CA
- Stage
- Series A
- Raised
- $15M
What it does
- AI chart summarization inside the EHR
- Ask Evidently chat pre-loaded with full chart
- CDI review and denial appeal support
- HCC capture and care gap reconciliation
- Note drafting for admits and discharges
- Registry abstraction and pre-op review
Where it's strong
- One chart-intelligence layer serves clinicians, CDI teams, and value-based care, spreading cost across use cases.
- Named academic and health system customers with third-party validation, including a 31.7-point Net EHR Experience Score gain at Iowa measured by KLAS.
- Allina Health documented 6x ROI on the value-based care use case.
What buyers should weigh
- Deep EHR embedding means IT involvement and a real pilot; UNC ran 12 weeks before enterprise rollout.
- It surfaces documentation and HCC opportunities but does not autonomously code or bill.
- At $15M raised it is a smaller vendor taking on well-funded CDI incumbents.
Named customers
University of Iowa Health Care · Allina Health · UNC Health
Integrations
SmarterDx
Pre-bill AI review that finds missed revenue and quality
- Founded
- 2020
- HQ
- New York, NY
- Stage
- PE-backed (Smarter Technologies, a New Mountain Capital platform)
- Raised
- $71M
What it does
- Reviews 100% of inpatient charts pre-bill
- Finds missed diagnoses, DRG shifts, and CC/MCC capture
- Generates AI-drafted appeals for clinical denials
- SmarterNotes ties note generation to revenue cycle intelligence
- Shows clinical evidence trail for every recommendation
Where it's strong
- Physician-founded pre-bill engine with audited results: roughly $2M net new revenue per 10,000 discharges, a 98 KLAS satisfaction score, and reported 100% client retention.
- Reviews every discharge rather than a sample, which is what makes the second-look economics work.
- New Mountain Capital backing pairs it with Access Healthcare's services scale inside Smarter Technologies.
What buyers should weigh
- Now part of a PE roll-up (merged with Access Healthcare and Thoughtful.ai in May 2025), so expect cross-sell pressure and possible roadmap shifts toward the combined platform.
- Value is concentrated in inpatient DRG reimbursement; ambulatory-heavy or critical-access organizations will see less benefit.
- It functions as a second-look layer on top of your existing CDI team and tech, an added cost line rather than a replacement.
Named customers
Novant Health · McLaren Health Care · UAMS
Integrations
Compare against the rest of Revenue Integrity & Pre-Bill Review
Deciding between these two?
First Pass tracks Revenue Integrity & Pre-Bill Review every week: funding, launches, and what changed since this page was written.